| Year |
Citation |
Score |
| 2024 |
Saint-Lary L, Lacroix I, Leroy V, Sommet A. Integrase inhibitor drugs during pregnancy and congenital anomalies: A case/non-case study from the global pharmacovigilance database VigiBase®. Pharmacology Research & Perspectives. 12: e1247. PMID 39086081 DOI: 10.1002/prp2.1247 |
0.301 |
|
| 2024 |
Maillard O, Bun R, Laanani M, Verga-Gérard A, Leroy T, Gault N, Estellat C, Noize P, Kaguelidou F, Sommet A, Lapeyre-Mestre M, Fourrier-Réglat A, Weill A, Quantin C, Tubach F. Use of the French National Health Data System (SNDS) in pharmacoepidemiology: A systematic review in its maturation phase. Therapie. PMID 38834394 DOI: 10.1016/j.therap.2024.05.003 |
0.355 |
|
| 2024 |
Bordet C, Zureik M, Zelmat Y, Lafaurie M, Lapeyre-Mestre M, Sommet A, Mazieres J, Despas F. Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study. Cancer Treatment and Research Communications. 39: 100801. PMID 38447474 DOI: 10.1016/j.ctarc.2024.100801 |
0.359 |
|
| 2023 |
Barus R, Montastruc F, de Canecaude C, Bagheri H, Sommet A, Lapeyre-Mestre M. Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study. Expert Opinion On Drug Safety. 22: 1283-1287. PMID 37584264 DOI: 10.1080/14740338.2023.2247962 |
0.432 |
|
| 2022 |
Lafaurie M, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risk of Immune Thrombocytopenia After Influenza Vaccine. Jama Internal Medicine. 182: 444-445. PMID 35188544 DOI: 10.1001/jamainternmed.2021.8523 |
0.356 |
|
| 2021 |
Moulis G, Germain J, Rueter M, Lafaurie M, Aroichane M, Comont T, Mahévas M, Viallard JF, Chèze S, Ebbo M, Audia S, Leclerc-Teffahi S, Sommet A, Beyne-Rauzy O, Michel M, et al. Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study. American Journal of Hematology. PMID 34779031 DOI: 10.1002/ajh.26404 |
0.372 |
|
| 2021 |
Lafaurie M, Maquet J, Baricault B, Ekstrand C, Christiansen CF, Linder M, Bahmanyar S, Nørgaard M, Sailler L, Lapeyre-Mestre M, Sommet A, Moulis G. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study. British Journal of Haematology. PMID 34386974 DOI: 10.1111/bjh.17709 |
0.394 |
|
| 2021 |
Maquet J, Lafaurie M, Walter O, Sailler L, Sommet A, Lapeyre-Mestre M, Michel M, Moulis G. Epidemiology of autoimmune hemolytic anemia: a nationwide population-based study in France. American Journal of Hematology. PMID 33930203 DOI: 10.1002/ajh.26213 |
0.34 |
|
| 2021 |
Montastruc JL, Lafaurie M, de Canecaude C, Durrieu G, Sommet A, Montastruc F, Bagheri H. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database. British Journal of Clinical Pharmacology. PMID 33837554 DOI: 10.1111/bcp.14851 |
0.327 |
|
| 2021 |
De Canecaude C, Rousseau V, Sommet A, Montastruc JL. Tramadol-induced hypoglycemia: A pharmacovigilance study. Fundamental & Clinical Pharmacology. PMID 33511683 DOI: 10.1111/fcp.12655 |
0.326 |
|
| 2020 |
Araujo M, Hurault-Delarue C, Sommet A, Damase-Michel C, Benevent J, Lacroix I. Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database. Therapie. PMID 32736872 DOI: 10.1016/J.Therap.2020.07.002 |
0.389 |
|
| 2020 |
Lemaitre F, Solas C, Grégoire M, Lagarce L, Elens L, Polard E, Saint-Salvi B, Sommet A, Tod M, Barin-Le Guellec C. Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments. Fundamental & Clinical Pharmacology. PMID 32603486 DOI: 10.1111/Fcp.12586 |
0.441 |
|
| 2020 |
Maquet J, Lafaurie M, Sommet A, Moulis G, Alvarez M, Amar J, Attal M, Balardy L, Balen F, Beyne-Rauzy O, Bouali O, Bounes F, Bureau C, Buscail L, et al. Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19. British Journal of Haematology. PMID 32557535 DOI: 10.1111/Bjh.16950 |
0.559 |
|
| 2020 |
Moulis G, Comont T, Germain J, Sommet A, Lapeyre-Mestre M, Beyne-Rauzy O, Adoue D. Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry. Blood Advances. 4: 1974-1977. PMID 32384539 DOI: 10.1182/Bloodadvances.2020001664 |
0.406 |
|
| 2020 |
Lafaurie M, Baricault B, Soler V, Cassagne M, Sailler L, Lapeyre-Mestre M, Sommet A, Moulis G. No increased risk of cataract in adult patients with primary immune thrombocytopenia treated with eltrombopag. A French nationwide nested case-control study. British Journal of Haematology. PMID 32155284 DOI: 10.1111/Bjh.16561 |
0.458 |
|
| 2019 |
Sommet A, Pariente A. Methods in pharmacoepidemiology. Therapie. PMID 30819408 DOI: 10.1016/J.Therap.2018.11.015 |
0.431 |
|
| 2019 |
Benevent J, Araujo M, Hurault-Delarue C, Montastruc JL, Sommet A, Lacroix I, Damase-Michel C. Pharmacoepidemiology in pregnancy. Therapie. PMID 30797568 DOI: 10.1016/J.Therap.2018.11.014 |
0.343 |
|
| 2019 |
Montastruc JL, Montastruc F, Benevent J, Lacroix I, Durrieu G, Du Plantier JM, Bagheri H, Sommet A, Damase-Michel C. Tintin in the Land of Drugs: A pharmacological, pharmacovigilance approach. Therapie. PMID 30686639 DOI: 10.1016/J.Therap.2019.01.002 |
0.388 |
|
| 2019 |
Sommet A. Interest of pharmacoepidemiology for the study of antibiotic drugs. Therapie. PMID 30678847 DOI: 10.1016/J.Therap.2018.10.005 |
0.4 |
|
| 2019 |
Lafaurie M, Baricault B, Soler V, Cassagne M, Sailler L, Lapeyre-Mestre M, Sommet A, Moulis G. No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study Blood. 134: 2363-2363. DOI: 10.1182/Blood-2019-124729 |
0.48 |
|
| 2019 |
Lafaurie M, Baricault B, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risk of Immune Thrombocytopenia Induced By Influenza Vaccine. a Nationwide Population-Based Study in France Blood. 134: 1086-1086. DOI: 10.1182/Blood-2019-124720 |
0.478 |
|
| 2019 |
Lafaurie M, Baricault B, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risque de purpura thrombopénique immunologique après vaccination contre la grippe. Étude populationnelle en France La Revue De MéDecine Interne. 40: A55. DOI: 10.1016/J.Revmed.2019.10.050 |
0.473 |
|
| 2019 |
Lafaurie M, Baricault B, Soler V, Cassagne M, Sailler L, Lapeyre-Mestre M, Sommet A, Moulis G. Risque de cataracte associé à l’exposition à l’eltrombopag dans le traitement de la thrombopénie immunologique. Étude populationnelle en France La Revue De MéDecine Interne. 40: A41. DOI: 10.1016/J.Revmed.2019.10.026 |
0.476 |
|
| 2019 |
Montastruc F, Benevent J, Rousseau V, Montastruc G, Durrieu G, Sommet A, Montastruc J. Risk of diabetes associated with statins and fibrates and their association: A disproportionality analysis using the WHO spontaneous reporting database, Vigibase® Archives of Cardiovascular Diseases Supplements. 11: 153. DOI: 10.1016/J.Acvdsp.2018.10.339 |
0.336 |
|
| 2018 |
Montastruc JL, Benevent J, Montastruc F, Bagheri H, Despas F, Lapeyre-Mestre M, Sommet A. What is pharmacoepidemiology? Definition, methods, interest and clinical applications. Therapie. PMID 30389102 DOI: 10.1016/J.Therap.2018.08.001 |
0.558 |
|
| 2018 |
Montastruc F, Benevent J, Rousseau V, Durrieu G, Sommet A, Montastruc JL. Risk of Diabetes with Fibrates and Statins: a pharmacoepidemiological study in Vigibase. Fundamental & Clinical Pharmacology. PMID 30098074 DOI: 10.1111/Fcp.12406 |
0.34 |
|
| 2018 |
Montastruc F, Khosrow-Khavar F, de Germay S, Renoux C, Rousseau V, Durrieu G, Montastruc M, Rascol O, Sommet A, Lapeyre-Mestre M, Benevent J, Montastruc JL. Tamoxifen and the risk of Parkinsonism: a case/non-case study. European Journal of Clinical Pharmacology. PMID 29862427 DOI: 10.1007/S00228-018-2496-3 |
0.439 |
|
| 2018 |
Kaguelidou F, Sommet A, Lapeyre-Mestre M. Use of French healthcare insurance databases in pediatric pharmacoepidemiology. Therapie. PMID 29588074 DOI: 10.1016/J.Therap.2017.11.008 |
0.478 |
|
| 2018 |
Rwagitinywa J, Lapeyre-Mestre M, Bourrel R, Montastruc JL, Sommet A. Comparison of adherence to generic multi-tablet regimens versus brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients. Fundamental & Clinical Pharmacology. PMID 29505661 DOI: 10.1111/Fcp.12363 |
0.497 |
|
| 2018 |
Couderc S, Lapeyre-Mestre M, Bourrel R, Carle P, Montastruc JL, Sommet A. Infectious risk of biological drugs versus traditional systemic treatments in moderate to severe psoriasis: a cohort analysis in the French insurance database. Fundamental & Clinical Pharmacology. PMID 29446857 DOI: 10.1111/Fcp.12358 |
0.548 |
|
| 2018 |
Rwagitinywa J, Sommet A, Palmaro A, Montastruc JL, Lapeyre-Mestre M. Utilization and costs of HIV antiretroviral drugs in Europe during the last ten years: Impact of generic antiretroviral drugs on cost reduction. Health Policy (Amsterdam, Netherlands). PMID 29398158 DOI: 10.1016/J.Healthpol.2018.01.002 |
0.518 |
|
| 2018 |
Lafaurie M, Baricault B, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risk of Vaccine-Induced Immune Thrombocytopenia in Children. Nationwide Case Cross-over and Self-Controlled Case Series Studies in France Blood. 132: 738-738. DOI: 10.1182/Blood-2018-99-110522 |
0.45 |
|
| 2017 |
Rwagitinywa J, Lapeyre-Mestre M, Bourrel R, Sommet A. Generic antiretroviral drug use in HIV-infected patients: A cohort study from the French health insurance database. Therapie. PMID 29195713 DOI: 10.1016/J.Therap.2017.10.001 |
0.515 |
|
| 2017 |
Sommet A, Lapeyre-Mestre M. Drug Use and Mortality in Parkinson Disease. Journal of the American Medical Directors Association. PMID 28866352 DOI: 10.1016/J.Jamda.2017.07.015 |
0.525 |
|
| 2017 |
Casaurancq MC, Campaigno EP, Rueter M, Baricault B, Bourrel R, Lapeyre-Mestre M, Sommet A. [Outpatient consumption of antibiotics with a bacterial resistance risk in 2014 in France]. Therapie. PMID 28647106 DOI: 10.1016/J.Therap.2017.03.002 |
0.422 |
|
| 2017 |
Thu Trang D, Cool C, Laffon de Mazieres C, Lapeyre-Mestre M, Montastruc JL, Rascol O, Rolland Y, Sommet A. Mortality and Antipsychotic Drug Use in Elderly Patients With Parkinson Disease in Nursing Homes. Journal of the American Medical Directors Association. PMID 28623157 DOI: 10.1016/J.Jamda.2017.04.014 |
0.491 |
|
| 2017 |
Caillet C, Sichanh C, Assemat G, Malet-Martino M, Sommet A, Bagheri H, Sengxeu N, Mongkhonmath N, Mayxay M, Syhakhang L, Lapeyre-Mestre M, Newton PN, Roussin A. Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People's Democratic Republic. Drug Safety. PMID 28528487 DOI: 10.1007/S40264-017-0544-Z |
0.521 |
|
| 2017 |
Lafaurie M, Baricault B, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risque de purpura thrombopénique immunologique post-vaccinal chez l’enfant. Case cross-over et self-controlled case series . Étude populationnelle en France La Revue De MéDecine Interne. 38: A56. DOI: 10.1016/J.Revmed.2017.10.330 |
0.475 |
|
| 2017 |
Casaurancq M, Rueter M, Baricault B, de Campaigno EP, Araujo M, Lapeyre-Mestre M, Sommet A. Outpatient Antibiotic Prescriptions with High Risk of Bacterial Resistance in France: A National Healthcare Insurance Database Analysis Clinical Therapeutics. 39: e12. DOI: 10.1016/J.Clinthera.2017.05.039 |
0.448 |
|
| 2016 |
Montastruc JL, Durriel G, Lacroix I, Lapeyre-Mestre M, Damase-Michel C, Bagheri H, Sommet A. Which pharmacovigilance for vaccines? Bulletin De L'Academie Nationale De Medecine. 200: 241-250. PMID 29898320 DOI: 10.1016/S0001-4079(19)30755-1 |
0.521 |
|
| 2016 |
Bounes V, Charriton-Dadone B, Levraut J, Delangue C, Carpentier F, Mary-Chalon S, Houze-Cerfon V, Sommet A, Houze-Cerfon CH, Ganetsky M. Predicting morphine related side effects in the emergency department: An international cohort study. The American Journal of Emergency Medicine. PMID 28117179 DOI: 10.1016/J.Ajem.2016.11.053 |
0.544 |
|
| 2016 |
Linselle M, Sommet A, Bondon-Guitton E, Moulis F, Durrieu G, Benevent J, Rousseau V, Chebane L, Bagheri H, Montastruc F, Montastruc JL. Can drugs induce or aggravate Sleep Apneas? A case non case Study in Vigibase(®) , the WHO Pharmacovigilance Database. Fundamental & Clinical Pharmacology. PMID 28036099 DOI: 10.1111/Fcp.12264 |
0.442 |
|
| 2016 |
Molinier A, Palmaro A, Rousseau V, Sommet A, Bourrel R, Montastruc JL, Bagheri H. Does substitution of brand name medications by generics differ between pharmacotherapeutic classes? A population-based cohort study in France. European Journal of Clinical Pharmacology. PMID 28035437 DOI: 10.1007/S00228-016-2185-Z |
0.304 |
|
| 2016 |
Montastruc J, Durrieu G, Lacroix I, Lapeyre-Mestre M, Damase-Michel C, Bagheri H, Sommet A. Quelle PharmacoVigilance pour les vaccins ? Bulletin De L'AcadéMie Nationale De MéDecine. 200: 241-250. DOI: 10.1016/s0001-4079(19)30755-1 |
0.361 |
|
| 2015 |
Montastruc JL, Sommet A, Montastruc F, Moulis G, Bagheri H, Damase-michel C, Lapeyre-mestre M. [Pharmacoepidemiology: definition, methods and applications]. Bulletin De L'Academie Nationale De Medecine. 199: 263-73; discussion 2. PMID 27476308 DOI: 10.1016/S0001-4079(19)30970-7 |
0.559 |
|
| 2015 |
Courrier V, Fournier JP, Sommet A, Montastruc JL, Poutrain JC. Parenteral anticoagulants use in general practice: a cross-sectional study in South Western France. Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 21: 319-24. PMID 25225242 DOI: 10.1177/1076029614548057 |
0.309 |
|
| 2015 |
Couderc S, Bourrel R, Paul C, Montastruc J, Lapeyre-Mestre M, Sommet A. Infectious risk of biological drugs versus conventional systemic treatments in moderate to severe psoriasis Clinical Therapeutics. 37: e4. DOI: 10.1016/J.Clinthera.2015.05.020 |
0.581 |
|
| 2014 |
Pochard L, Hauviller L, Cuzin L, Eyvrard F, Sommet A, Montastruc JL, Bagheri H. [Use of Nadis(®) software to improve adverse drug reaction reporting of antiretroviral drugs: experience in south west of France (midi-pyrénées)]. Therapie. 69: 149-55. PMID 24926633 DOI: 10.2515/Therapie/2013076 |
0.445 |
|
| 2014 |
Moulis G, Sommet A, Lapeyre-Mestre M, Montastruc JL. Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database. Rheumatology (Oxford, England). 53: 1864-71. PMID 24899660 DOI: 10.1093/Rheumatology/Keu214 |
0.49 |
|
| 2014 |
Fournier JP, Sommet A, Durrieu G, Poutrain JC, Lapeyre-Mestre M, Montastruc JL. More on the "triple Whammy": Antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury-a case/non-case study in the French pharmacovigilance database Renal Failure. 36: 1166-1168. PMID 24826803 DOI: 10.3109/0886022X.2014.917943 |
0.59 |
|
| 2014 |
Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, et al. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. Plos One. 9: e82222. PMID 24404128 DOI: 10.1371/Journal.Pone.0082222 |
0.438 |
|
| 2014 |
Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Derumeaux H, Adoue D. Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity. American Journal of Hematology. 89: 41-6. PMID 24038066 DOI: 10.1002/Ajh.23580 |
0.464 |
|
| 2014 |
Fournier JP, Sommet A, Durrieu G, Poutrain JC, Lapeyre-Mestre M, Montastruc JL. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database. Fundamental & Clinical Pharmacology. 28: 230-5. PMID 23190210 DOI: 10.1111/Fcp.12014 |
0.602 |
|
| 2013 |
Le Moigne M, Sommet A, Lapeyre-Mestre M, Bourrel R, Molinier L, Paul C, Montastruc JL. Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance database. Journal of the European Academy of Dermatology and Venereology : Jeadv. 28: 1235-44. PMID 24236509 DOI: 10.1111/Jdv.12318 |
0.537 |
|
| 2013 |
Sommet A, Georgel B, Poutrain JC, Oustric S, Bourrel R, Montastruc JL, Birebent J. [Generic substitution in primary care in 2011: differences according to pharmacological classes?]. Revue D'Epidemiologie Et De Sante Publique. 61: 539-44. PMID 24211149 DOI: 10.1016/J.Respe.2013.08.001 |
0.301 |
|
| 2013 |
Dupouy J, Moulis G, Tubery M, Ecoiffier M, Sommet A, Poutrain JC, Arlet P, Lapeyre-Mestre M. Which adverse events are related to health care during hospitalization in elderly inpatients? International Journal of Medical Sciences. 10: 1224-30. PMID 23935400 DOI: 10.7150/Ijms.6640 |
0.678 |
|
| 2013 |
Moulis G, Sommet A, Lapeyre-Mestre M. Mortality rates among patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: comment on the article by Simard et al. Arthritis and Rheumatism. 65: 1670-1. PMID 23508973 DOI: 10.1002/art.37931 |
0.372 |
|
| 2013 |
Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Adoue D. Prevalence of pneumococcal vaccination in adult immune thrombocytopenia patients exposed to rituximab or to splenectomy. European Journal of Haematology. 90: 438-9. PMID 23444912 DOI: 10.1111/Ejh.12091 |
0.438 |
|
| 2013 |
Danton AC, Montastruc F, Sommet A, Durrieu G, Bagheri H, Bondon-Guitton E, Lapeyre-Mestre M, Montastruc JL. Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France. European Journal of Clinical Pharmacology. 69: 885-8. PMID 22996074 DOI: 10.1007/S00228-012-1394-3 |
0.584 |
|
| 2013 |
Moulis G, Sommet A, Lapeyre-Mestre M, Montastruc J. Le risque de lupus induit par anti-TNF alpha est-il le même selon les différents anti-TNF-alpha ? Une étude cas/non-cas dans la base nationale française de pharmacovigilance La Revue De MéDecine Interne. 34: A72. DOI: 10.1016/J.Revmed.2013.10.110 |
0.439 |
|
| 2013 |
Le Moigne M, Sommet A, Lapeyre-Mestre M, Bourrel R, Molinier L, Montastruc J, Paul C. Impact économique des biothérapies dans le psoriasis en comparaison aux traitements systémiques classiques: analyse des données de l’Assurance maladie Annales De Dermatologie Et De VéNéRéOlogie. 140: S428-S429. DOI: 10.1016/J.Annder.2013.09.144 |
0.462 |
|
| 2012 |
Sommet A, Ferrières N, Jaoul V, Cadieux L, Soulat JM, Lapeyre-Mestre M, Montastruc JL. Use of drugs, tobacco, alcohol and illicit substances in a French student population. Therapie. 67: 429-35. PMID 23241252 DOI: 10.2515/Therapie/2012056 |
0.471 |
|
| 2012 |
Moulis G, Sommet A, Béné J, Montastruc F, Sailler L, Montastruc JL, Lapeyre-Mestre M. Cancer risk of anti-TNF-α at recommended doses in adult rheumatoid arthritis: a meta-analysis with intention to treat and per protocol analyses. Plos One. 7: e48991. PMID 23155441 DOI: 10.1371/Journal.Pone.0048991 |
0.501 |
|
| 2012 |
Fournier JP, Sommet A, Bourrel R, Oustric S, Pathak A, Lapeyre-Mestre M, Montastruc JL. Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. European Journal of Clinical Pharmacology. 68: 1533-40. PMID 22527348 DOI: 10.1007/S00228-012-1283-9 |
0.537 |
|
| 2012 |
Fournier JP, Lapeyre-Mestre M, Sommet A, Dupouy J, Poutrain JC, Montastruc JL. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study. Plos One. 7: e34187. PMID 22479557 DOI: 10.1371/Journal.Pone.0034187 |
0.742 |
|
| 2012 |
Moulis G, Sommet A, Durrieu G, Bagheri H, Lapeyre-Mestre M, Montastruc JL. Trends of reporting of 'serious'vs. 'non-serious' adverse drug reactions over time: a study in the French PharmacoVigilance Database. British Journal of Clinical Pharmacology. 74: 201-4. PMID 22257367 DOI: 10.1111/J.1365-2125.2012.04185.X |
0.568 |
|
| 2012 |
Sommet A, Durrieu G, Lapeyre-Mestre M, Montastruc JL. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006. Pharmacoepidemiology and Drug Safety. 21: 285-8. PMID 22162094 DOI: 10.1002/Pds.2307 |
0.516 |
|
| 2012 |
Montastruc F, Sommet A, Bondon-Guitton E, Durrieu G, Bui E, Bagheri H, Lapeyre-Mestre M, Schmitt L, Montastruc JL. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. European Journal of Clinical Pharmacology. 68: 767-75. PMID 22116460 DOI: 10.1007/S00228-011-1156-7 |
0.591 |
|
| 2012 |
Moulis G, Sommet A, Sailler L, Lapeyre-Mestre M, Montastruc JL. Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database. Platelets. 23: 490-4. PMID 22098130 DOI: 10.3109/09537104.2011.633179 |
0.581 |
|
| 2012 |
Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Montastruc JL. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study. Pharmacoepidemiology and Drug Safety. 21: 314-9. PMID 21953992 DOI: 10.1002/Pds.2253 |
0.48 |
|
| 2012 |
Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Recher C, Alric L, Arlet P, Adoue D. Incidence des complications locales post-chirurgicales de la splénectomie pour purpura thrombopénique immunologique primaire de l’adulte : étude monocentrique de 62 patients consécutifs La Revue De MéDecine Interne. 33: A102. DOI: 10.1016/J.Revmed.2012.10.154 |
0.471 |
|
| 2012 |
Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Recher C, Alric L, Arlet P, Adoue D. Prophylaxie infectieuse chez les patients adultes exposés au rituximab ou à la splénectomie pour purpura thrombopénique immunologique primaire La Revue De MéDecine Interne. 33: A101-A102. DOI: 10.1016/J.Revmed.2012.10.153 |
0.462 |
|
| 2012 |
Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Recher C, Alric L, Arlet P, Adoue D. Comparaison de la splénectomie et du rituximab dans la thrombopénie immunologique primaire de l’adulte : étude dans une cohorte monocentrique de 105 patients La Revue De MéDecine Interne. 33: A57. DOI: 10.1016/J.Revmed.2012.10.067 |
0.472 |
|
| 2011 |
Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. British Journal of Clinical Pharmacology. 72: 905-8. PMID 21658092 DOI: 10.1111/J.1365-2125.2011.04037.X |
0.572 |
|
| 2011 |
Moulis G, Béné J, Sommet A, Sailler L, Lapeyre-Mestre M, Montastruc J. Lupus induit par les statines : étude cas/non-cas dans la banque française de Pharmacovigilance La Revue De MéDecine Interne. 32: S292-S293. DOI: 10.1016/J.Revmed.2011.10.357 |
0.432 |
|
| 2011 |
Moulis G, Sommet A, Béné J, Montastruc F, Sailler L, Montastruc J, Lapeyre-Mestre M. Risque de cancer sous anti-TNF-α chez les patients adultes atteints de polyarthrite rhumatoïde : méta-analyse de 33 essais cliniques randomisés La Revue De MéDecine Interne. 32: S274-S275. DOI: 10.1016/J.Revmed.2011.10.322 |
0.444 |
|
| 2011 |
Moulis G, Sommet A, Bagheri H, Durrieu G, Lapeyre-Mestre M, Montastruc J. Notification des effets indésirables graves et non graves au cours du temps : étude dans la banque nationale française de pharmacovigilance La Revue De MéDecine Interne. 32: S133-S134. DOI: 10.1016/J.Revmed.2011.03.210 |
0.46 |
|
| 2011 |
Moulis G, Sailler L, Sommet A, Montastruc J, Lapeyre-Mestre M. Insuffisance rénale aiguë induite par les immunoglobulines polyvalentes intraveineuses : facteurs associés à la nécessité de dialyse La Revue De MéDecine Interne. 32: S61-S62. DOI: 10.1016/J.Revmed.2011.03.052 |
0.451 |
|
| 2011 |
Dupouy J, Moulis G, Tubery M, Ecoiffier M, Sommet A, Poutrain J, Arlet P, Lapeyre-Mestre M. Iatrogénie intra-hospitalière dans un service de médecine interne - post-urgences médicales La Revue De MéDecine Interne. 32: S61. DOI: 10.1016/J.Revmed.2011.03.051 |
0.646 |
|
| 2010 |
Boudal P, Sommet A, Bagheri H, Pathak A, Montastruc JL. Bleedings induced by oral anticoagulants: a study of adverse drug reactions reported to Midi-Pyrénées PharmacoVigilance Centre between 2003 and 2006. Thã©Rapie. 65: 567-9. PMID 21176763 DOI: 10.2515/Therapie/2010065 |
0.348 |
|
| 2010 |
Gallini A, Degris E, Desplas M, Bourrel R, Archambaud M, Montastruc JL, Lapeyre-Mestre M, Sommet A. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. The Journal of Antimicrobial Chemotherapy. 65: 2650-7. PMID 20876240 DOI: 10.1093/Jac/Dkq351 |
0.436 |
|
| 2010 |
Montastruc JL, Durrieu G, Sommet A, Damase-Michel C, Lapeyre-Mestre M. Anticholinergics, antimuscarinics or atropinics? About the words in pharmacology. British Journal of Clinical Pharmacology. 69: 561-2. PMID 20573094 DOI: 10.1111/J.1365-2125.2010.03633.X |
0.436 |
|
| 2010 |
Gony M, Badie K, Sommet A, Jacquot J, Baudrin D, Gauthier P, Montastruc JL, Bagheri H. Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study. Drug Safety. 33: 409-16. PMID 20397740 DOI: 10.2165/11319170-000000000-00000 |
0.435 |
|
| 2010 |
Montastruc G, Favreliere S, Sommet A, Pathak A, Lapeyre-Mestre M, Perault-Pochat MC, Montastruc JL. Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database. British Journal of Clinical Pharmacology. 69: 287-94. PMID 20233200 DOI: 10.1111/J.1365-2125.2009.03596.X |
0.586 |
|
| 2010 |
Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Montastruc J. Insuffisance rénale aiguë induite par les immunoglobulines polyvalentes intraveineuses : enquête descriptive à partir de la banque nationale française de pharmacovigilance La Revue De MéDecine Interne. 31: S359-S360. DOI: 10.1016/J.Revmed.2010.10.048 |
0.455 |
|
| 2009 |
Sommet A, Shams R, Valnet-Rabier MB, Jean-Pastor MJ, Castot A, Lapeyre-Mestre M, Montastruc JL. [Drugs and heat wave: SIRIUS, a multicentric case-control study in patients older than 65 years during 2007 summer in France]. Therapie. 64: 295-301. PMID 19863904 DOI: 10.2515/Therapie/2009044 |
0.54 |
|
| 2009 |
Tavassoli N, Lapeyre-Mestre M, Sommet A, Montastruc JL. Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol). British Journal of Clinical Pharmacology. 68: 422-6. PMID 19740400 DOI: 10.1111/J.1365-2125.2009.03472.X |
0.749 |
|
| 2009 |
Sommet A, Castot A, Montastruc JL. Heat waves and the elderly. Adverse drug events. Bmj (Clinical Research Ed.). 339: b3146. PMID 19654180 DOI: 10.1136/Bmj.B3146 |
0.354 |
|
| 2009 |
Sommet A, Lapeyre-Mestre M, Castot A, Montastruc J. Sirius : étude cas-témoins multicentrique française sur les médicaments et leurs posologies chez les plus de 65 ans en cas de forte chaleur Revue D'éPidéMiologie Et De Santé Publique. 57: S84. DOI: 10.1016/J.Respe.2009.07.048 |
0.436 |
|
| 2008 |
Sommet A, Grolleau S, Bagheri H, Lapeyre-Mestre M, Montastruc JL. Was the thrombotic risk of rofecoxib predictable from the French Pharmacovigilance Database before 30 September 2004? European Journal of Clinical Pharmacology. 64: 829-34. PMID 18509626 DOI: 10.1007/S00228-008-0497-3 |
0.517 |
|
| 2008 |
Gallini A, Sommet A, Montastruc JL. Does memantine induce bradycardia? A study in the French PharmacoVigilance Database. Pharmacoepidemiology and Drug Safety. 17: 877-81. PMID 18500725 DOI: 10.1002/Pds.1620 |
0.405 |
|
| 2008 |
Sommet A, Bagheri H, Lapeyre-Mestre M, Montastruc JL. Did thirst-blockers contribute to the exorbitant number of fatalities during the French 2003 heat wave? Pharmacoepidemiology and Drug Safety. 17: 312-3. PMID 18300324 DOI: 10.1002/Pds.1548 |
0.409 |
|
| 2008 |
Durrieu G, Lacroix I, Olivier P, Sommet A, Sénard JM, Montastruc JL. [Drug-related neuropathies: analysis of the French Adverse Drug Reaction Database 1995-2005]. Presse MéDicale (Paris, France : 1983). 37: 935-42. PMID 18242948 DOI: 10.1016/J.Lpm.2007.08.020 |
0.448 |
|
| 2007 |
Tavassoli N, Sommet A, Lapeyre-Mestre M, Bagheri H, Montrastruc JL. Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary). Drug Safety. 30: 1063-71. PMID 17973542 DOI: 10.2165/00002018-200730110-00005 |
0.764 |
|
| 2007 |
Gallini A, Sommet A, Salandini AM, Veyssière P, Montastruc JL, Montastruc JL. Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1980-1. PMID 17657810 DOI: 10.1002/Mds.21669 |
0.338 |
|
| 2007 |
Biga J, Gony M, Bourrel R, Souche A, Sommet A, Pathak A, Sciortino V, Taboulet F, Grand A, Lapeyre-Mestre M, Montastruc JL. Coxibs: evolution of prescription's behaviour in France. Fundamental & Clinical Pharmacology. 21: 317-25. PMID 17521301 DOI: 10.1111/J.1472-8206.2007.00489.X |
0.485 |
|
| 2007 |
Sommet A, Desplas M, Lapeyre-Mestre M, Montastruc JL. Drug-induced yawning: a review of the French pharmacovigilance database. Drug Safety. 30: 327-31. PMID 17408309 DOI: 10.2165/00002018-200730040-00005 |
0.567 |
|
| 2007 |
Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, Muoz MJ, Sie P, Honorato J, Montastruc JL, Bagheri H. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. European Journal of Clinical Pharmacology. 63: 221-8. PMID 17225990 DOI: 10.1007/S00228-006-0242-8 |
0.751 |
|
| 2007 |
Michenot F, Sommet A, Bagheri H, Lapeyre-Mestre M, Montastruc JL. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database. Pharmacoepidemiology and Drug Safety. 15: 735-40. PMID 16924603 DOI: 10.1002/Pds.1284 |
0.532 |
|
| 2006 |
Bandrant M, Bagheri H, Cuzin L, Sommet A, Bassoua V, Guitton E, Bonnet E, Garipuy D, Lucas F, Aquilina C, Montastruc JL, Massip P. [Not Available]. Therapie. 61: 171-6. PMID 27393319 DOI: 10.2515/Therapie:2006024 |
0.793 |
|
| 2006 |
Montastruc JL, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M, Bagheri H. Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods. Joint, Bone, Spine : Revue Du Rhumatisme. 73: 629-32. PMID 17110152 DOI: 10.1016/J.Jbspin.2006.09.002 |
0.528 |
|
| 2006 |
Baudrant M, Bagheri H, Cuzin L, Sommet A, Bassoua V, Guitton E, Bonnet E, Garipuy D, Lucas F, Aquilina C, Montastruc JL, Massip P. [Analysis of antiretroviral drugs-induced adverse effects]. Thã©Rapie. 61: 171-6. PMID 16886711 |
0.795 |
|
| 2006 |
Montastruc JL, Sommet A, Olivier P, Bagheri H, Gony M, Lapeyre-Mestre M, Brefel-Courbon C, Ferreira J, Schmitt L, Senard JM, Rascol O. [Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]. Therapie. 61: 29-38. PMID 16792152 DOI: 10.2515/Therapie:2006011 |
0.538 |
|
| 2006 |
Tavassoli N, Bagheri H, Sommet A, Delpierre C, Marion-Latard F, Massip P, Aquilina C, Bonnet E, Obadia M, Labau E, Montastruc JL, Bernard J. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry. Pharmacotherapy. 26: 154-61. PMID 16466321 DOI: 10.1592/Phco.26.2.154 |
0.647 |
|
| 2006 |
Tavassoli N, Sommet A, Montastruc J. Drug Interactions with Cholinesterase Inhibitors: an Analysis of the French Pharmacovigilance Database Drug Safety. 29: 911-1010. DOI: 10.2165/00002018-200629100-00064 |
0.396 |
|
| 2006 |
Montastruc J, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M, Bagheri H. La pharmacovigilance et l'évaluation du risque médicamenteux: intérêt, fonctionnement et méthodes Revue Du Rhumatisme. 73: 1021-1024. DOI: 10.1016/J.Rhum.2006.09.008 |
0.446 |
|
| 2005 |
Sommet A, Juillard-Condat B, Cestac P, Lapeyre-Mestre M, Montastruc JL. [Methods for the measurement of drug consumption: application to antibiotics]. Therapie. 60: 553-9. PMID 16555492 DOI: 10.2515/Therapie:2005077 |
0.555 |
|
| 2005 |
Sommet A, Azaïs-Vuillemin C, Bagheri H, Rascol O, Montastruc JL. Trimetazidine: a new cause for drug-induced parkinsonism? Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1080-1. PMID 16007626 DOI: 10.1002/Mds.20574 |
0.396 |
|
| 2005 |
Mbongue TB, Sommet A, Pathak A, Montastruc JL. "Medicamentation" of society, non-diseases and non-medications: a point of view from social pharmacology. European Journal of Clinical Pharmacology. 61: 309-13. PMID 15895268 DOI: 10.1007/S00228-005-0925-6 |
0.347 |
|
| Show low-probability matches. |